Alnylam Pharmaceuticals shares owned by Abbrea Capital
Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Abbrea Capital
from 13F filings
Historical chart of Abbrea Capital investment in Alnylam Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals held by Abbrea Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals by Abbrea Capital
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $213k | 1.4k | 149.47 |
| 2023-12-31 | $273k | 1.4k | 191.58 |
| 2023-09-30 | $252k | 1.4k | 176.84 |
| 2023-06-30 | $271k | 1.4k | 190.18 |
| 2023-03-31 | $285k | 1.4k | 200.00 |
| 2022-12-31 | $374k | 1.6k | 237.65 |
| 2022-09-30 | $315k | 1.6k | 200.00 |
| 2022-06-30 | $230k | 1.6k | 146.03 |
| 2022-03-31 | $257k | 1.6k | 163.17 |
| 2021-12-31 | $267k | 1.6k | 169.52 |
| 2021-09-30 | $297k | 1.6k | 188.57 |
| 2021-06-30 | $267k | 1.6k | 169.52 |
| 2021-03-31 | $222k | 1.6k | 140.95 |